Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias

• Published in: Journal of pediatric urology Vol. 16; no. 5; pp. 689.e1 - 689.e12
• Main Authors: Mares, L., Vilchis, F., Chávez, B., Ramos, L.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2020
• Subjects: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase - genetics; 46,XY Disorders of sex development; Aldo-Keto Reductase Family 1 Member C3; Androgens; Backdoor pathway; Child; Child, Preschool; DHT; Dihydrotestosterone; Female; Humans; Hydroxysteroid Dehydrogenases - genetics; Hypospadias; Hypospadias - genetics; Infant; Male; Membrane Proteins; Molecular Biology; Oxidoreductases; Pediatrics; Racemases and Epimerases; Single-nucleotide polymorphism; Steroidogenesis; Testosterone; Urology; DHT; Steroidogenesis; Single-nucleotide polymorphism; 46,XY Disorders of sex development; Hypospadias; Backdoor pathway; hypospadias; backdoor pathway; 46, XY Disorders of Sex Development; single-nucleotide polymorphism
• DOI: 10.1016/j.jpurol.2020.07.001
• ISSN: 1477-5131; 1873-4898

The formation of the male urethra depends to enzyme-mediated testosterone (T) conversion into 5α-dihydrotestosterone (DHT). Two metabolic pathways could be operating in the fetal testis to synthesize androgens: 1) the “classic” route (T→DHT) mediated by SRD5A2 and 2) a “backdoor” pathway in which DHT is synthesized by aldo-keto reductase family 1, member C2 (AKR1C2), AKR1C3, and AKR1C4 enzymes without formation of a T intermediate. We studied four genes of the “backdoor” pathway in karyotypic males with hypospadias to ascertain whether gene defects in AKRs impair urethral DHT formation that result in hypospadias. The coding regions of the AKR1C2-4 and HSD17B6 genes were analyzed by PCR-SSCP and sequencing in a cohort of 25 Mexican patients (0.3–9 year-old-children) with 46,XY-hypospadias. Chi-squared tests was performed to evaluate the distribution of genotypes, alleles, and the Hardy-Weinberg (H-W) equilibrium. The effect of the genetic variants was investigated by in silico studies. Screening studies revealed distinct genotypic patterns at different exons of AKR1C2-4 whereas HSD17B6 presented a wild-type sequence. The DNA analyses detected two synonymous variants (c.327C>T, c.666T>C/unreported) in AKR1C2. The AKR1C3 had two variants (c.15C>G, c.230A>G), two unreported variants (c.538T>C, c.596G>A), and one silent variant (c.312G>A). Two variants (c.434C>G, c.931C>G) were identified in AKR1C4. All variants were in H-W equilibrium without structural changes. Hypospadias have been associated with defects that alter androgen biosynthesis in the human fetal testis, specifically 5α-DHT. We selected four candidate genes involved in the “backdoor” pathway for the formation of 5α-DHT. Molecular assays of the AKR1C2, AKR1C3, and AKR1C4 genes revealed a total of nine genetic single nucleotide variants. Several variants in the AKR1C genes have been associated with a variety of human pathologies. However, our studies suggest that active steroid biosynthesis via AKR1C might not be involved in hypospadias. Additionally, genetic research suggests a low involvement in the “backdoor” 5α-DHT pathway during human sexual development, specifically, the differentiation of male external genitalia. These results indicate that substitutions in AKR1C2-4 are polymorphisms and all genetic variants lacks deleterious significant association with hypospadias. The data suggest that inactivating mutations in the AKR1C2-4 and HSD17B6 genes are an infrequent cause of hypospadias, which might weaken the contribution of the “backdoor” pathway to embryonic urethral masculinization. [Display omitted]